Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia

Douglas W. Losordo, Peter R. Vale, Robert C. Hendel, Charles E. Milliken, F. David Fortuin, Nancie Cummings, Richard A. Schatz, Takayuki Asahara, Jeffrey M. Isner, Richard E. Kuntz

Research output: Contribution to journalArticle

414 Scopus citations

Fingerprint Dive into the research topics of 'Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia'. Together they form a unique fingerprint.

Medicine & Life Sciences